Conference paper Open Access

Dysregulation of mutant ALK2: More than just loss of binding of inhibitory factors

Williams, E. P.; Bullock, A. N.

Poster presented at the Biochemical Society Conference: BMP Signalling in Cancer II held at St. Annes college in Oxford, April 2019. You can read more about it here on the SGC open notebook.

Funding Acknowledgment: The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.
Files (5.3 MB)
Name Size
5.3 MB Download
All versions This version
Views 158158
Downloads 4343
Data volume 225.9 MB225.9 MB
Unique views 139139
Unique downloads 3838


Cite as